Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms

Aging Male

Volumn 11, Issue 2, 2008, Pages 95-99

  Tsujimura, Akira ^a   Takada, Shingo ^a   Matsuoka, Yasuhiro ^a   Nakayama, Jiro ^a   Takao, Tetsuya ^a   Miyagawa, Yasushi ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

LOH related symptoms; Saikokaryukotsuboreito

Indexed keywords

SAIKO KA RYUKOTSU BOREI TO;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSURIA; HUMAN; HYPOGONADISM; NOCTURIA; POLLAKISURIA; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDER; TESTOSTERONE BLOOD LEVEL;

ADULT; AGE OF ONSET; AGED; DRUGS, CHINESE HERBAL; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 45849106554     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530802172529     Document Type: Article

References (38)

1. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74-86.
2. Morley JE. Androgens and aging. Maturitas 2001;38:61-71; discussion 71-63.
3. Morales A, Buvat J, Gooren LJ, Guay AT, Kaufman JM, Tan HM, Torres LO. Endocrine aspects of sexual dysfunction in men. J Sex Med 2004;1:69-81.
4. Morley JE, Perry HM, III. Androgen deficiency in aging men. Med Clin North Am 1999;83:1279-1289, vii.
5. Vermeulen A. Andropause. Maturitas 2000;34:5-15.
6. Morales A, Heaton JP, Carson CC, III. Andropause: A misnomer for a true clinical entity. J Urol 2000;163:705-712.
7. Tsujimura A, Matsumiya K, Matsuoka Y, Takahashi T, Koga M, Iwasa A, Takeyama M, Okuyama A. Bioavailable testosterone with age and erectile dysfunction. J Urol 2003;170:2345-2347.
8. Morley JE. Testosterone replacement and the physiologic aspects of aging in men. Mayo Clin Proc 2000;75:S83-87.
9. Morley JE. Testosterone replacement in older men and women. J Gend Specif Med 2001;4:49-53.
10. Morley JE, Perry HM, III. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003;85:367-373.
11. Comhaire FH. Andropause: Hormone replacement therapy in the ageing male. Eur Urol 2000;38:655-662.
12. Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: Assessment of biochemical measures and therapeutic outcomes. J Urol 1997;157:849-854.
13. T'Sjoen G, Feyen E, De Kuyper P, Comhaire F, Kaufman JM. Self-referred patients in an aging male clinic: Much more than androgen deficiency alone. Aging Male 2003;6:157-165.
14. T'Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 2004;29:201-214.
15. Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S, Koga M, Iwasa A, Takeyama M, Okuyama A. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int J Impot Res 2005;17:259-263.
16. Miwa Y, Kaneda T, Yokoyama O. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723-726.
17. Chen JT, Shiraki M. Menopausal hot flash and calciotonin gene-related peptide; Effect of Keishi-bukuryo-gan, a kampo medicine, related to plasma calciotonin gene-related peptide level. Maturitas 2003;45:199-204.
18. Ushiroyama T, Ikeda A, Sakuma K, Ueki M. Changes in serum tumor necrosis factor (TNF-alpha) with kami-shoyosan administration in depressed climacteric patients. Am J Chin Med 2004;32:621-629.
19. Heinemann LA, Zimmermann T, Vermeulen A, Thiel C. A new 'aging males' symptoms' (AMS) rating scale. Aging Male 1999;2:105-114.
20. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965;13:508-515.
21. Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-1557; discussion 1564.
22. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997;104:1374-1379.
23. Yoshida NM, Kumano H, Kuboki T. Does the Aging Males' Symptoms scale assess major depressive disorder? A pilot study. Maturitas 2006;53:171-175.
24. Sato Y, Tanda H, Kato S, Onishi S, Nakajima H, Nanbu A, Nitta T, Koroku M, Akagashi K, Hanzawa T. Prevalence of major depressive disorder in self-referred patients in a late onset hypogonadism clinic. Int J Impot Res 2007;19:407-410.
25. Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev 2003;CD003383.
26. Shevtsov VA, Zholus BI, Shervarly VI, Vol'skij VB, Korovin YP, Khristich MP, Roslyakova NA, Wikman G. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 2003;10:95-105.
27. Ushiroyama T, Ikeda A, Sakuma K, Ueki M. Chai-hu-gui-zhigan-jiang-tang regulates plasma interleukin-6 and soluble interleukin-6 receptor concentrations and improves depressed mood in climacteric women with insomnia. Am J Chin Med 2005;33:703-711.
28. Pan B, Kato Y, Sengoku K, Takuma N, Niizeki N, Ishikawa M. Treatment of climacteric symptoms with herbal formulas of traditional Chinese medicine. Gynecol Obstet Invest 2004;57:144-148.
29. Park SW, Kim YK, Lee JG, Kim SH, Kim JM, Yoon JS, Park YK, Lee YK, Kim YH. Antidepressant-like effects of the traditional Chinese medicine kami-shoyo-san in rats. Psychiatry Clin Neurosci 2007;61:401-406.
30. Saltzman EA, Guay AT, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: A clinical observation. J Urol 2004;172:255-258.
31. Nomura S, Hattori N, Sakakibara I, Fukuhara S. Effects of Saiko-ka-ryukotsu-borei-to in patients with hyperlipidemia. Phytomedicine 2001;8:165-173.
32. Sarai K. Oriental medicine as therapy for resistant depression: Use of some herbal drugs in the Far East (Japan). Prog Neuropsychopharmacol Biol Psychiatry 1992;16:171-180.
33. Kanba S, Yamada K, Mizushima H, Asai M. Use of herbal medicine for treating psychiatric disorders in Japan. Psychiatry Clin Neurosci 1998;52:S331-333.
34. Sasaki K, Suzuki K, Yoshizaki F, Ando T. Effect of saiko-ka-ryukotsu- borei-to on the stress-induced increase of serum corticosterone in mice. Biol Pharm Bull 1995;18:563-565.
35. Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Tabira T. Saiko-ka-ryukotsu-borei-to, an herbal medicine, prevents chronic stress-induced disruption of glucocorticoid negative feedback in rats. Life Sci 2002;72:67-77.
36. Mizoguchi K, Yuzurihara M, Ishige A, Aburada M, Tabira T. Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance. Pharmacol Biochem Behav 2003;75:419-425.
37. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092-1098.
38. Tsujimura A, Matsumiya K, Takao T, Miyagawa Y, Takada S, Koga M, Iwasa A, Takeyama M, Okuyama A. Treatment with human chorionic gonadotropin for PADAM: A preliminary report. Aging Male 2005;8:175-179.